Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey
JCO Global Oncology · 2026-04 · 12 (4)
DOI: 10.1200/go-25-00582 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2026-04. Verfasst von Rajat Das Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Public Health and Environmental Research, Bangladesh (CIPHER,B), Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Breast Neoplasms. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE This study examined the determinants of breast and cervical cancer screening and quantified socioeconomic inequalities in service use. METHODS We analyzed data from women age 15-49 years from the 2023 Tajikistan Demographic and Health Survey. The outcomes were self-reported ever having received a clinical breast examination for breast cancer and ever having been tested for cervical cancer. The prevalence was estimated using weighted descriptive statistics and Rao-Scott chi-square tests. Determinants were examined with multivariable logistic regression, reporting adjusted odds ratios (AORs), and 95% confidence intervals. Socioeconomic inequality was assessed using concentration curves and concentration indices, accounting for the complex survey design. RESULTS The final sample size was 9,824. Breast and cervical cancer screening prevalence was 6.2% and 9.3%, respectively. Uptake increased with age (25-34 years: breast AOR = 2.68; cervical AOR = 2.41; 35-49 years: breast AOR = 3.54; cervical AOR = 3.27, v 15-24 years) and with household wealth (richest v poorest, cervical AOR = 1.95). Higher screening odds were associated with parity, recent health care visits, contraceptive use, and media exposure, whereas lower odds were associated with nonmotorized transport use. The prevalence was greater in urban areas. Concentration indices showed significant pro-rich inequality for both screening services (breast = 0.05; cervical = 0.05; P < .001). CONCLUSION Strategies prioritizing integrating screening into reproductive and primary care, expanding outreach to poorer households, ensuring financial protection, and delivering community-based services in rural areas, alongside monitoring equity indicators, are critical to advancing universal access to breast and cervical cancer screening in Tajikistan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for International Public Health and Environmental Research, Bangladesh (CIPHER,B), Dhaka, Bangladesh.
- BRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
- School of Economic, Political, and Policy Sciences, The University of Texas at Dallas, Richardson, TX.
- Health Data Management Project, Friendship NGO, Dhaka, Bangladesh.
- Department of Public Health, School of Health and Life Science, North South University, Bashundhara, Dhaka, Bangladesh.
ORCID-Profile: Rajat Das Gupta, Shams Shabab Haider, Ananna Mazumder
Zitieren
APA
Gupta, R. D., Sarker, P., Haider, S. S., Mazumder, A., Gupta, A. D., & Chakraborty, P. A. (2026). Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey. JCO Global Oncology, 12(4). https://doi.org/10.1200/go-25-00582
Vancouver
Gupta RD, Sarker P, Haider SS, Mazumder A, Gupta AD, Chakraborty PA. Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey. JCO Global Oncology. 2026;12(4). doi:10.1200/go-25-00582
BibTeX
@article{Gupta2026,
author = {Gupta, Rajat Das and Sarker, Poulami and Haider, Shams Shabab and Mazumder, Ananna and Gupta, Arpan Das and Chakraborty, Promit Ananyo},
title = {Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {4},
doi = {10.1200/go-25-00582}
}
EUVIMED